PMC:7463108 / 37405-37556 JSONTXT

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T373","span":{"begin":82,"end":90},"obj":"Chemical"},{"id":"T374","span":{"begin":115,"end":123},"obj":"Chemical"}],"attributes":[{"id":"A373","pred":"chebi_id","subj":"T373","obj":"http://purl.obolibrary.org/obo/CHEBI_17303"},{"id":"A374","pred":"chebi_id","subj":"T374","obj":"http://purl.obolibrary.org/obo/CHEBI_17303"},{"id":"A375","pred":"chebi_id","subj":"T374","obj":"http://purl.obolibrary.org/obo/CHEBI_58097"}],"text":"atter/oligodendroglial pathology\nChanges in OL survival and morphology Tat1–86 No Morphine (25 mg pellet, 7 days); morphine (in vitro) • ↑ Degeneration"}